Skip to main content
Home

Main navigation

  • Top stories
  • Health
  • Crime
  • Politics
  • Business
  • Tech
  • Culture
  • Sports
  • Weird
  • 1-1-2
Image
Hugo de Jonge debating with a reporter during a press conference on 8 Dec. 2020
Hugo de Jonge debating with a reporter during a press conference on 8 Dec. 2020 - Credit: RVD / Minister-President / Facebook
Health
Politics
Coronavirus
coronavirus vaccine
Covid-19
Hugo de Jonge
GGD
Tuesday, 5 January 2021 - 08:42
Share this:
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • reddit

Dutch health minister losing public support over slow Covid vaccine rollout

About 44 percent of people in the Netherlands have less confidence in Health Minister Hugo de Jonge because of the country’s vaccination policy, according to a poll conducted by news program Hart van Nederland. Another 44 percent said their support for De Jonge has remained the same, while eight percent said their confidence in his job performance has grown.

About a third of respondents said they want him to step down.

The survey of about three thousand people showed that De Jonge lost support because of the confusion about who would first be able to get vaccinated and the slow start to the vaccination process. The Netherlands will inoculate its first resident, a care home nurse, on Wednesday. The country will be the last in the European Union to begin distributing its first vaccines.

The Cabinet rescheduled the start date twice. One of the main delays was the upgrade of an IT system to allow municipal health service GGD to track scheduling appointments, and which vaccine candidate was used on different patients. The GGD also needed to establish at least one mass vaccination point in each of its 25 regions.

De Jonge said on Monday that it may have been possible to start vaccinating people “a few days earlier” if he had asked the GGD system to begin scaling up preparations at an earlier date. De Jonge was likely to face criticism during emergency debates in Parliament this week.

Currently, only a vaccine from Pfizer/BioNTech has been approved for use. The European Medicines Agency could issue a ruling on a candidate from Moderna on Wednesday, and a rolling review of the AstraZeneca/Oxford University candidate could be concluded later this month.

Follow us:

Latest stories

  • PvdA and GroenLinks in Brabant: only together in provincial government
  • Human trafficking near asylum seekers’ center in Gilze systematically not picked up
  • 20-year-old driver from Utrecht dies in car accident on A6
  • OM defends preventive arrests for demonstration on A12
  • Schiphol holds job fair, more than 1300 visitors expected
  • Millions of passport photos of innocent foreigners in police face database

Top stories

  • Hoekstra wants to reintroduce conscription
  • EU countries agree on new price cap for Russian oil
  • Hermitage shows Rembrandt and contemporaries from The Leiden Collection
  • Dutch police take down Exclu encrypted chat service with 42 arrests, €4 million seized
  • Signal failure briefly halts train traffic around A'dam; NS warns of significant delays
  • Matching medicine dosage to patient's DNA can cut side effects 30%: LUMC

© 2012-2023, NL Times, All rights reserved.

Footer menu

  • Privacy
  • Contact
  • Partner content